Multicellular Quadruple Colorectal Cancer Spheroids as an In Vitro Tool for Antiangiogenic Potential Evaluation of Nanoparticles

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.contributorUniversidade Estadual Paulista (UNESP)-
Autor(es): dc.contributorUniversity of Porto-
Autor(es): dc.contributorIUCS-
Autor(es): dc.creatorCarvalho, Suzana-
Autor(es): dc.creatorSilveira, Maria José-
Autor(es): dc.creatorDomingues, Mariana-
Autor(es): dc.creatorFerreira, Bárbara-
Autor(es): dc.creatorPereira, Catarina Leite-
Autor(es): dc.creatorGremião, Maria Palmira-
Autor(es): dc.creatorSarmento, Bruno-
Data de aceite: dc.date.accessioned2025-08-21T22:31:02Z-
Data de disponibilização: dc.date.available2025-08-21T22:31:02Z-
Data de envio: dc.date.issued2023-07-29-
Data de envio: dc.date.issued2023-07-29-
Data de envio: dc.date.issued2023-04-01-
Fonte completa do material: dc.identifierhttp://dx.doi.org/10.1002/adtp.202200282-
Fonte completa do material: dc.identifierhttp://hdl.handle.net/11449/246703-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/11449/246703-
Descrição: dc.descriptionThe encapsulation of bevacizumab (BVZ), angiogenesis inhibitor antibody, into nanocarriers is explored aiming at enhancing its efficacy in colorectal cancer (CRC) treatment while eliminating potential side effects. Still, the translation of such nanomedicines into clinics is not straightforward owing to their preclinical screening in simplistic models, that do not mimic the complexity and heterogeneity of the CRC microenvironment. Herein, the development of a multicellular spheroid of CRC as an advanced preclinical model of CRC capable of screening the antiangiogenic potential of novel nanomedicines is proposed. For that, a quadruple co-culture is established through the combination of HCT116 cells, human pulmonary microvascular endothelial cell (HPMEC), fibroblasts, and macrophages. It is demonstrated that the developed model displays intrinsic CRC features, such as the organization of cells, expression of tumor microenvironment, extracellular matrix, and the formation of a necrotic core. Moreover, the model is shown to be composed mostly of HCT116 (93%), followed by hypoxia-inducible factor (3%), HPMEC (3%), and macrophages (1%). Gellan gum/chitosan nanoparticles encapsulating BVZ exhibit superior antiangiogenic properties when compared to free BVZ. Overall, the developed nanoparticles can further be explored as a promising approach in CRC treatment.-
Descrição: dc.descriptionSchool of Pharmaceutical Sciences São Paulo State University (UNESP), SP-
Descrição: dc.descriptioni3S – Instituto de Investigação e Inovação em Saúde University of Porto-
Descrição: dc.descriptionINEB – Instituto de Engenharia Biomédica University of Porto-
Descrição: dc.descriptionCESPU IUCS-
Descrição: dc.descriptionSchool of Pharmaceutical Sciences São Paulo State University (UNESP), SP-
Idioma: dc.languageen-
Relação: dc.relationAdvanced Therapeutics-
???dc.source???: dc.sourceScopus-
Palavras-chave: dc.subjectangiogenesis-
Palavras-chave: dc.subjectbevacizumab-
Palavras-chave: dc.subjectcolorectal cancer-
Palavras-chave: dc.subjectdrug delivery-
Palavras-chave: dc.subjectmulticellular tumor spheroids-
Palavras-chave: dc.subjectpolymeric nanoparticles-
Palavras-chave: dc.subjecttumor microenvironment-
Título: dc.titleMulticellular Quadruple Colorectal Cancer Spheroids as an In Vitro Tool for Antiangiogenic Potential Evaluation of Nanoparticles-
Tipo de arquivo: dc.typelivro digital-
Aparece nas coleções:Repositório Institucional - Unesp

Não existem arquivos associados a este item.